Seasonal influenza vaccines are medical products used to prevent influenza virus infection and reduce the severity of flu symptoms during flu seasons.

The global Seasonal Influenza Vaccines Therapeutics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

The market for seasonal influenza vaccines is driven by the demand for preventive healthcare measures and the need to reduce the burden of seasonal flu on healthcare systems. The market's growth is also influenced by the growing emphasis on vaccination and immunization programs globally.

This report aims to provide a comprehensive presentation of the global market for Seasonal Influenza Vaccines Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Seasonal Influenza Vaccines Therapeutics.

Report Scope

The Seasonal Influenza Vaccines Therapeutics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Seasonal Influenza Vaccines Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Seasonal Influenza Vaccines Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Seasonal Influenza Vaccines Therapeutics Market Report

Report Metric	Details
Report Name	Seasonal Influenza Vaccines Therapeutics Market
Segment by Type	Paediatrics Adolescence Adults Elderly
Segment by Application	Hospitals Clinics Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	GSK, Novartis, CSL, MedImmune, Sanofi-Pasteur, Solvay, Hualan Biological Engineering, Sinovac Biotech, Changchun Institute of Biological Products Co., Ltd., Shanghai Institute of Biological Products Co., Ltd.
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Seasonal Influenza Vaccines Therapeutics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Seasonal Influenza Vaccines Therapeutics Market report?

Ans: The main players in the Seasonal Influenza Vaccines Therapeutics Market are GSK, Novartis, CSL, MedImmune, Sanofi-Pasteur, Solvay, Hualan Biological Engineering, Sinovac Biotech, Changchun Institute of Biological Products Co., Ltd., Shanghai Institute of Biological Products Co., Ltd.

What are the Application segmentation covered in the Seasonal Influenza Vaccines Therapeutics Market report?

Ans: The Applications covered in the Seasonal Influenza Vaccines Therapeutics Market report are Hospitals, Clinics, Others

What are the Type segmentation covered in the Seasonal Influenza Vaccines Therapeutics Market report?

Ans: The Types covered in the Seasonal Influenza Vaccines Therapeutics Market report are Paediatrics, Adolescence, Adults, Elderly

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Seasonal Influenza Vaccines Therapeutics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Paediatrics

1.2.3 Adolescence

1.2.4 Adults

1.2.5 Elderly

1.3 Market by Application

1.3.1 Global Seasonal Influenza Vaccines Therapeutics Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Hospitals

1.3.3 Clinics

1.3.4 Others

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Seasonal Influenza Vaccines Therapeutics Market Perspective (2019-2030)

2.2 Seasonal Influenza Vaccines Therapeutics Growth Trends by Region

2.2.1 Global Seasonal Influenza Vaccines Therapeutics Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Seasonal Influenza Vaccines Therapeutics Historic Market Size by Region (2019-2024)

2.2.3 Seasonal Influenza Vaccines Therapeutics Forecasted Market Size by Region (2025-2030)

2.3 Seasonal Influenza Vaccines Therapeutics Market Dynamics

2.3.1 Seasonal Influenza Vaccines Therapeutics Industry Trends

2.3.2 Seasonal Influenza Vaccines Therapeutics Market Drivers

2.3.3 Seasonal Influenza Vaccines Therapeutics Market Challenges

2.3.4 Seasonal Influenza Vaccines Therapeutics Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Seasonal Influenza Vaccines Therapeutics Players by Revenue

3.1.1 Global Top Seasonal Influenza Vaccines Therapeutics Players by Revenue (2019-2024)

3.1.2 Global Seasonal Influenza Vaccines Therapeutics Revenue Market Share by Players (2019-2024)

3.2 Global Seasonal Influenza Vaccines Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Seasonal Influenza Vaccines Therapeutics Revenue

3.4 Global Seasonal Influenza Vaccines Therapeutics Market Concentration Ratio

3.4.1 Global Seasonal Influenza Vaccines Therapeutics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Seasonal Influenza Vaccines Therapeutics Revenue in 2023

3.5 Seasonal Influenza Vaccines Therapeutics Key Players Head office and Area Served

3.6 Key Players Seasonal Influenza Vaccines Therapeutics Product Solution and Service

3.7 Date of Enter into Seasonal Influenza Vaccines Therapeutics Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Seasonal Influenza Vaccines Therapeutics Breakdown Data by Type

4.1 Global Seasonal Influenza Vaccines Therapeutics Historic Market Size by Type (2019-2024)

4.2 Global Seasonal Influenza Vaccines Therapeutics Forecasted Market Size by Type (2025-2030)

5 Seasonal Influenza Vaccines Therapeutics Breakdown Data by Application

5.1 Global Seasonal Influenza Vaccines Therapeutics Historic Market Size by Application (2019-2024)

5.2 Global Seasonal Influenza Vaccines Therapeutics Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Seasonal Influenza Vaccines Therapeutics Market Size (2019-2030)

6.2 North America Seasonal Influenza Vaccines Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Seasonal Influenza Vaccines Therapeutics Market Size by Country (2019-2024)

6.4 North America Seasonal Influenza Vaccines Therapeutics Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Seasonal Influenza Vaccines Therapeutics Market Size (2019-2030)

7.2 Europe Seasonal Influenza Vaccines Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Seasonal Influenza Vaccines Therapeutics Market Size by Country (2019-2024)

7.4 Europe Seasonal Influenza Vaccines Therapeutics Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Seasonal Influenza Vaccines Therapeutics Market Size (2019-2030)

8.2 Asia-Pacific Seasonal Influenza Vaccines Therapeutics Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Seasonal Influenza Vaccines Therapeutics Market Size by Region (2019-2024)

8.4 Asia-Pacific Seasonal Influenza Vaccines Therapeutics Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Seasonal Influenza Vaccines Therapeutics Market Size (2019-2030)

9.2 Latin America Seasonal Influenza Vaccines Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Seasonal Influenza Vaccines Therapeutics Market Size by Country (2019-2024)

9.4 Latin America Seasonal Influenza Vaccines Therapeutics Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Seasonal Influenza Vaccines Therapeutics Market Size (2019-2030)

10.2 Middle East & Africa Seasonal Influenza Vaccines Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Seasonal Influenza Vaccines Therapeutics Market Size by Country (2019-2024)

10.4 Middle East & Africa Seasonal Influenza Vaccines Therapeutics Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 GSK

11.1.1 GSK Company Detail

11.1.2 GSK Business Overview

11.1.3 GSK Seasonal Influenza Vaccines Therapeutics Introduction

11.1.4 GSK Revenue in Seasonal Influenza Vaccines Therapeutics Business (2019-2024)

11.1.5 GSK Recent Development

11.2 Novartis

11.2.1 Novartis Company Detail

11.2.2 Novartis Business Overview

11.2.3 Novartis Seasonal Influenza Vaccines Therapeutics Introduction

11.2.4 Novartis Revenue in Seasonal Influenza Vaccines Therapeutics Business (2019-2024)

11.2.5 Novartis Recent Development

11.3 CSL

11.3.1 CSL Company Detail

11.3.2 CSL Business Overview

11.3.3 CSL Seasonal Influenza Vaccines Therapeutics Introduction

11.3.4 CSL Revenue in Seasonal Influenza Vaccines Therapeutics Business (2019-2024)

11.3.5 CSL Recent Development

11.4 MedImmune

11.4.1 MedImmune Company Detail

11.4.2 MedImmune Business Overview

11.4.3 MedImmune Seasonal Influenza Vaccines Therapeutics Introduction

11.4.4 MedImmune Revenue in Seasonal Influenza Vaccines Therapeutics Business (2019-2024)

11.4.5 MedImmune Recent Development

11.5 Sanofi-Pasteur

11.5.1 Sanofi-Pasteur Company Detail

11.5.2 Sanofi-Pasteur Business Overview

11.5.3 Sanofi-Pasteur Seasonal Influenza Vaccines Therapeutics Introduction

11.5.4 Sanofi-Pasteur Revenue in Seasonal Influenza Vaccines Therapeutics Business (2019-2024)

11.5.5 Sanofi-Pasteur Recent Development

11.6 Solvay

11.6.1 Solvay Company Detail

11.6.2 Solvay Business Overview

11.6.3 Solvay Seasonal Influenza Vaccines Therapeutics Introduction

11.6.4 Solvay Revenue in Seasonal Influenza Vaccines Therapeutics Business (2019-2024)

11.6.5 Solvay Recent Development

11.7 Hualan Biological Engineering

11.7.1 Hualan Biological Engineering Company Detail

11.7.2 Hualan Biological Engineering Business Overview

11.7.3 Hualan Biological Engineering Seasonal Influenza Vaccines Therapeutics Introduction

11.7.4 Hualan Biological Engineering Revenue in Seasonal Influenza Vaccines Therapeutics Business (2019-2024)

11.7.5 Hualan Biological Engineering Recent Development

11.8 Sinovac Biotech

11.8.1 Sinovac Biotech Company Detail

11.8.2 Sinovac Biotech Business Overview

11.8.3 Sinovac Biotech Seasonal Influenza Vaccines Therapeutics Introduction

11.8.4 Sinovac Biotech Revenue in Seasonal Influenza Vaccines Therapeutics Business (2019-2024)

11.8.5 Sinovac Biotech Recent Development

11.9 Changchun Institute of Biological Products Co., Ltd.

11.9.1 Changchun Institute of Biological Products Co., Ltd. Company Detail

11.9.2 Changchun Institute of Biological Products Co., Ltd. Business Overview

11.9.3 Changchun Institute of Biological Products Co., Ltd. Seasonal Influenza Vaccines Therapeutics Introduction

11.9.4 Changchun Institute of Biological Products Co., Ltd. Revenue in Seasonal Influenza Vaccines Therapeutics Business (2019-2024)

11.9.5 Changchun Institute of Biological Products Co., Ltd. Recent Development

11.10 Shanghai Institute of Biological Products Co., Ltd.

11.10.1 Shanghai Institute of Biological Products Co., Ltd. Company Detail

11.10.2 Shanghai Institute of Biological Products Co., Ltd. Business Overview

11.10.3 Shanghai Institute of Biological Products Co., Ltd. Seasonal Influenza Vaccines Therapeutics Introduction

11.10.4 Shanghai Institute of Biological Products Co., Ltd. Revenue in Seasonal Influenza Vaccines Therapeutics Business (2019-2024)

11.10.5 Shanghai Institute of Biological Products Co., Ltd. Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Hualan Biological Engineering

SINOVAC BIOTECH

Changchun Institute of Biological Products Co., Ltd.

Shanghai Institute of Biological Products Co., Ltd.

List of Tables

Table 1. Global Seasonal Influenza Vaccines Therapeutics Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Paediatrics

Table 3. Key Players of Adolescence

Table 4. Key Players of Adults

Table 5. Key Players of Elderly

Table 6. Global Seasonal Influenza Vaccines Therapeutics Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 7. Global Seasonal Influenza Vaccines Therapeutics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 8. Global Seasonal Influenza Vaccines Therapeutics Market Size by Region (2019-2024) & (US$ Million)

Table 9. Global Seasonal Influenza Vaccines Therapeutics Market Share by Region (2019-2024)

Table 10. Global Seasonal Influenza Vaccines Therapeutics Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 11. Global Seasonal Influenza Vaccines Therapeutics Market Share by Region (2025-2030)

Table 12. Seasonal Influenza Vaccines Therapeutics Market Trends

Table 13. Seasonal Influenza Vaccines Therapeutics Market Drivers

Table 14. Seasonal Influenza Vaccines Therapeutics Market Challenges

Table 15. Seasonal Influenza Vaccines Therapeutics Market Restraints

Table 16. Global Seasonal Influenza Vaccines Therapeutics Revenue by Players (2019-2024) & (US$ Million)

Table 17. Global Seasonal Influenza Vaccines Therapeutics Market Share by Players (2019-2024)

Table 18. Global Top Seasonal Influenza Vaccines Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Seasonal Influenza Vaccines Therapeutics as of 2023)

Table 19. Ranking of Global Top Seasonal Influenza Vaccines Therapeutics Companies by Revenue (US$ Million) in 2023

Table 20. Global 5 Largest Players Market Share by Seasonal Influenza Vaccines Therapeutics Revenue (CR5 and HHI) & (2019-2024)

Table 21. Key Players Headquarters and Area Served

Table 22. Key Players Seasonal Influenza Vaccines Therapeutics Product Solution and Service

Table 23. Date of Enter into Seasonal Influenza Vaccines Therapeutics Market

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Seasonal Influenza Vaccines Therapeutics Market Size by Type (2019-2024) & (US$ Million)

Table 26. Global Seasonal Influenza Vaccines Therapeutics Revenue Market Share by Type (2019-2024)

Table 27. Global Seasonal Influenza Vaccines Therapeutics Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 28. Global Seasonal Influenza Vaccines Therapeutics Revenue Market Share by Type (2025-2030)

Table 29. Global Seasonal Influenza Vaccines Therapeutics Market Size by Application (2019-2024) & (US$ Million)

Table 30. Global Seasonal Influenza Vaccines Therapeutics Revenue Market Share by Application (2019-2024)

Table 31. Global Seasonal Influenza Vaccines Therapeutics Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 32. Global Seasonal Influenza Vaccines Therapeutics Revenue Market Share by Application (2025-2030)

Table 33. North America Seasonal Influenza Vaccines Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 34. North America Seasonal Influenza Vaccines Therapeutics Market Size by Country (2019-2024) & (US$ Million)

Table 35. North America Seasonal Influenza Vaccines Therapeutics Market Size by Country (2025-2030) & (US$ Million)

Table 36. Europe Seasonal Influenza Vaccines Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 37. Europe Seasonal Influenza Vaccines Therapeutics Market Size by Country (2019-2024) & (US$ Million)

Table 38. Europe Seasonal Influenza Vaccines Therapeutics Market Size by Country (2025-2030) & (US$ Million)

Table 39. Asia-Pacific Seasonal Influenza Vaccines Therapeutics Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 40. Asia-Pacific Seasonal Influenza Vaccines Therapeutics Market Size by Region (2019-2024) & (US$ Million)

Table 41. Asia-Pacific Seasonal Influenza Vaccines Therapeutics Market Size by Region (2025-2030) & (US$ Million)

Table 42. Latin America Seasonal Influenza Vaccines Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 43. Latin America Seasonal Influenza Vaccines Therapeutics Market Size by Country (2019-2024) & (US$ Million)

Table 44. Latin America Seasonal Influenza Vaccines Therapeutics Market Size by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Seasonal Influenza Vaccines Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 46. Middle East & Africa Seasonal Influenza Vaccines Therapeutics Market Size by Country (2019-2024) & (US$ Million)

Table 47. Middle East & Africa Seasonal Influenza Vaccines Therapeutics Market Size by Country (2025-2030) & (US$ Million)

Table 48. GSK Company Detail

Table 49. GSK Business Overview

Table 50. GSK Seasonal Influenza Vaccines Therapeutics Product

Table 51. GSK Revenue in Seasonal Influenza Vaccines Therapeutics Business (2019-2024) & (US$ Million)

Table 52. GSK Recent Development

Table 53. Novartis Company Detail

Table 54. Novartis Business Overview

Table 55. Novartis Seasonal Influenza Vaccines Therapeutics Product

Table 56. Novartis Revenue in Seasonal Influenza Vaccines Therapeutics Business (2019-2024) & (US$ Million)

Table 57. Novartis Recent Development

Table 58. CSL Company Detail

Table 59. CSL Business Overview

Table 60. CSL Seasonal Influenza Vaccines Therapeutics Product

Table 61. CSL Revenue in Seasonal Influenza Vaccines Therapeutics Business (2019-2024) & (US$ Million)

Table 62. CSL Recent Development

Table 63. MedImmune Company Detail

Table 64. MedImmune Business Overview

Table 65. MedImmune Seasonal Influenza Vaccines Therapeutics Product

Table 66. MedImmune Revenue in Seasonal Influenza Vaccines Therapeutics Business (2019-2024) & (US$ Million)

Table 67. MedImmune Recent Development

Table 68. Sanofi-Pasteur Company Detail

Table 69. Sanofi-Pasteur Business Overview

Table 70. Sanofi-Pasteur Seasonal Influenza Vaccines Therapeutics Product

Table 71. Sanofi-Pasteur Revenue in Seasonal Influenza Vaccines Therapeutics Business (2019-2024) & (US$ Million)

Table 72. Sanofi-Pasteur Recent Development

Table 73. Solvay Company Detail

Table 74. Solvay Business Overview

Table 75. Solvay Seasonal Influenza Vaccines Therapeutics Product

Table 76. Solvay Revenue in Seasonal Influenza Vaccines Therapeutics Business (2019-2024) & (US$ Million)

Table 77. Solvay Recent Development

Table 78. Hualan Biological Engineering Company Detail

Table 79. Hualan Biological Engineering Business Overview

Table 80. Hualan Biological Engineering Seasonal Influenza Vaccines Therapeutics Product

Table 81. Hualan Biological Engineering Revenue in Seasonal Influenza Vaccines Therapeutics Business (2019-2024) & (US$ Million)

Table 82. Hualan Biological Engineering Recent Development

Table 83. Sinovac Biotech Company Detail

Table 84. Sinovac Biotech Business Overview

Table 85. Sinovac Biotech Seasonal Influenza Vaccines Therapeutics Product

Table 86. Sinovac Biotech Revenue in Seasonal Influenza Vaccines Therapeutics Business (2019-2024) & (US$ Million)

Table 87. Sinovac Biotech Recent Development

Table 88. Changchun Institute of Biological Products Co., Ltd. Company Detail

Table 89. Changchun Institute of Biological Products Co., Ltd. Business Overview

Table 90. Changchun Institute of Biological Products Co., Ltd. Seasonal Influenza Vaccines Therapeutics Product

Table 91. Changchun Institute of Biological Products Co., Ltd. Revenue in Seasonal Influenza Vaccines Therapeutics Business (2019-2024) & (US$ Million)

Table 92. Changchun Institute of Biological Products Co., Ltd. Recent Development

Table 93. Shanghai Institute of Biological Products Co., Ltd. Company Detail

Table 94. Shanghai Institute of Biological Products Co., Ltd. Business Overview

Table 95. Shanghai Institute of Biological Products Co., Ltd. Seasonal Influenza Vaccines Therapeutics Product

Table 96. Shanghai Institute of Biological Products Co., Ltd. Revenue in Seasonal Influenza Vaccines Therapeutics Business (2019-2024) & (US$ Million)

Table 97. Shanghai Institute of Biological Products Co., Ltd. Recent Development

Table 98. Research Programs/Design for This Report

Table 99. Key Data Information from Secondary Sources

Table 100. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Seasonal Influenza Vaccines Therapeutics Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Seasonal Influenza Vaccines Therapeutics Market Share by Type: 2023 VS 2030

Figure 3. Paediatrics Features

Figure 4. Adolescence Features

Figure 5. Adults Features

Figure 6. Elderly Features

Figure 7. Global Seasonal Influenza Vaccines Therapeutics Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 8. Global Seasonal Influenza Vaccines Therapeutics Market Share by Application: 2023 VS 2030

Figure 9. Hospitals Case Studies

Figure 10. Clinics Case Studies

Figure 11. Others Case Studies

Figure 12. Seasonal Influenza Vaccines Therapeutics Report Years Considered

Figure 13. Global Seasonal Influenza Vaccines Therapeutics Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 14. Global Seasonal Influenza Vaccines Therapeutics Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 15. Global Seasonal Influenza Vaccines Therapeutics Market Share by Region: 2023 VS 2030

Figure 16. Global Seasonal Influenza Vaccines Therapeutics Market Share by Players in 2023

Figure 17. Global Top Seasonal Influenza Vaccines Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Seasonal Influenza Vaccines Therapeutics as of 2023)

Figure 18. The Top 10 and 5 Players Market Share by Seasonal Influenza Vaccines Therapeutics Revenue in 2023

Figure 19. North America Seasonal Influenza Vaccines Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 20. North America Seasonal Influenza Vaccines Therapeutics Market Share by Country (2019-2030)

Figure 21. United States Seasonal Influenza Vaccines Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Canada Seasonal Influenza Vaccines Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Europe Seasonal Influenza Vaccines Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Europe Seasonal Influenza Vaccines Therapeutics Market Share by Country (2019-2030)

Figure 25. Germany Seasonal Influenza Vaccines Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. France Seasonal Influenza Vaccines Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. U.K. Seasonal Influenza Vaccines Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Italy Seasonal Influenza Vaccines Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Russia Seasonal Influenza Vaccines Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Nordic Countries Seasonal Influenza Vaccines Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Asia-Pacific Seasonal Influenza Vaccines Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Asia-Pacific Seasonal Influenza Vaccines Therapeutics Market Share by Region (2019-2030)

Figure 33. China Seasonal Influenza Vaccines Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Japan Seasonal Influenza Vaccines Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. South Korea Seasonal Influenza Vaccines Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Southeast Asia Seasonal Influenza Vaccines Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. India Seasonal Influenza Vaccines Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Australia Seasonal Influenza Vaccines Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Latin America Seasonal Influenza Vaccines Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Latin America Seasonal Influenza Vaccines Therapeutics Market Share by Country (2019-2030)

Figure 41. Mexico Seasonal Influenza Vaccines Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Brazil Seasonal Influenza Vaccines Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Middle East & Africa Seasonal Influenza Vaccines Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Middle East & Africa Seasonal Influenza Vaccines Therapeutics Market Share by Country (2019-2030)

Figure 45. Turkey Seasonal Influenza Vaccines Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Saudi Arabia Seasonal Influenza Vaccines Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. GSK Revenue Growth Rate in Seasonal Influenza Vaccines Therapeutics Business (2019-2024)

Figure 48. Novartis Revenue Growth Rate in Seasonal Influenza Vaccines Therapeutics Business (2019-2024)

Figure 49. CSL Revenue Growth Rate in Seasonal Influenza Vaccines Therapeutics Business (2019-2024)

Figure 50. MedImmune Revenue Growth Rate in Seasonal Influenza Vaccines Therapeutics Business (2019-2024)

Figure 51. Sanofi-Pasteur Revenue Growth Rate in Seasonal Influenza Vaccines Therapeutics Business (2019-2024)

Figure 52. Solvay Revenue Growth Rate in Seasonal Influenza Vaccines Therapeutics Business (2019-2024)

Figure 53. Hualan Biological Engineering Revenue Growth Rate in Seasonal Influenza Vaccines Therapeutics Business (2019-2024)

Figure 54. Sinovac Biotech Revenue Growth Rate in Seasonal Influenza Vaccines Therapeutics Business (2019-2024)

Figure 55. Changchun Institute of Biological Products Co., Ltd. Revenue Growth Rate in Seasonal Influenza Vaccines Therapeutics Business (2019-2024)

Figure 56. Shanghai Institute of Biological Products Co., Ltd. Revenue Growth Rate in Seasonal Influenza Vaccines Therapeutics Business (2019-2024)

Figure 57. Bottom-up and Top-down Approaches for This Report

Figure 58. Data Triangulation

Figure 59. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions